| Kreibohm, Philipp (Home24 Founder) |
n. a. |
|
|
| Kreienbühl, Kerstin (Endress+Hauser 201705 Industry Communication Manager) |
Public Relations Manager / Investor Relations Manager |
Endress+Hauser (Group) |
Switzerland |
| Kreis, Jürgen (Nynomic 202012 Managing Director of LemnaTec GmbH) |
Managing Director |
Nynomic (Group) |
Germany |
| Kreitman, Benjamin (Broadview Ventures 202105) |
Investment Manager |
Broadview Ventures Inc. |
|
| Kremer, Mathias (Bayer 201109 Head of BioScience business group of Bayer CropScience) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Kremoser, Claus (Phenex 201106 CEO) |
Chief Executive Officer (CEO) |
Phenex Pharmaceuticals AG |
Germany |
| Kresbach, Gerhard M. (EK Biosciences GmbH 201203 Managing Director + Co-founder before Zeptosens) |
n. a. |
EK Biosciences GmbH |
Switzerland |
| Kress, Jean-Paul (MorphoSys 201909– CEO before Syntimmune + Biogen + Sanofi Genzyme) |
Chief Executive Officer (CEO) |
MorphoSys (Group) |
Germany |
| Kretzschmar, Titus (1abtik AG 201510– CEO + Founder) |
Chief Executive Officer (CEO) |
1abtik AG |
Switzerland |
| Kreutzer, Roland (Roche Kulmbach 2007– Managing Director before Alnylam Europe 200602 Managing Director) |
Managing Director |
LGC (Group) |
Germany |
| Kreuz, Sebastian (Boehringer 20207 at Boehringer Ingelheim Venture Fund) |
Investment Manager |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Kreuzburg, Joachim (Sartorius 200305– CEO) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Germany |
| Kreuzer, Jörg (Boehringer Ingelheim 201604 VP Medicine, Therapeutic Area Cardiovascular) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Krey, Christian (Emperra GmbH –201605–201706 Managing Director LEFT 6/17) |
Managing Director |
Emperra GmbH E-Health Technologies |
Germany |
| Kreymann, Bernhard (Hepa Wash 200705 Managing Director + Founder) |
Managing Director |
Hepa Wash GmbH |
Germany |
| Krickl, Reinhard (Phagenesis 201609 CEO) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
United Kingdom (GB) |
| Krieg, Arthur (Art) (Checkmate Pharmaceuticals 201508 CEO + Founder) |
Chief Executive Officer (CEO) |
Regeneron (Group) |
United States (USA) |
| Kriegner, Albert (Platomics 201908 Managing Director + Founder) |
Managing Director |
Platomics GmbH |
Austria |
| Kriegsmann, Jörg (MVZ Trier + MPT Trier 201610 Professor + Founder + Owner) |
n. a. |
MVZ für Histologie, Zytologie und Molekulare Diagnostik Trier (Dr. Kriegsmann + Dr. Otto) |
Germany |
| Krietemeyer, Birgit (Conpega 201102 Managing Director Conpega Holding + Wiesbaden) |
Managing Director |
Conpega (Group) |
Germany |
| Kring, Michael Maximilian (High Tech Corporate Services GmbH 201402 Managing Director + interim CFO/CEO others) |
Managing Director |
High Tech Corporate Services GmbH |
Germany |
| Krishnamurthi, Ashok (GreatPoint Ventures 202102 Managing Partner formerly CAPP Medical 210504 CEO) |
Managing Partner |
GreatPoint Ventures (US) |
United States (USA) |
| Krishnan, Shiv (Sanofi 201810 Head of Technology Platforms, Global BusDev + Licensing) |
Business Development Manager / Strategy Manager |
Sanofi (Group) [since May 2011] |
France |
| Kriwet, Carla (Fresenius 202205–202212 CEO before BSH Hausgeräte + Royal Philips + Drägerwerk + Linde AG) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
Germany |
| Kroczek, Richard (AmpliVak Immunotherapy 201910– Managing Director) |
Managing Director |
AmpliVak Immunotherapy GmbH |
Germany |
| Kroeger, Georg (Lab-Q 200910) |
Consultant (economic/technology) |
Lab-Q Dr. Georg Kroeger |
Germany |
| Krogan, Nevan J. (Gladstone Institutes 201506 Senior Investigator + Director MS Facility + Prof at UCSF) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Gladstone Institutes (Group) |
United States (USA) |
| Krogsgaard Thomsen, Mads (Novo Nordisk 200702 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Novo Group (Group) |
Denmark |
| Krohn, Michael (BRAIN Biotech 202210– RnD Head of Akribion Genomics before RnD Head of BRAIN Biotech AG) |
President/Director/Head Business Group/Unit/Division |
BRAIN Biotech (Group) |
Germany |
| Kroke, Anja (Helmholtz 201110 Corporate Communications at Ascenion GmbH) |
Public Relations Manager / Investor Relations Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
| Kroll, Cordula (Eppendorf 201109 Executive Director Portfoliomanagement) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
| Kroll, Friedrich (Celeris Therapeutics 202202– VP of Drug Discovery) |
Research & Development Manager |
Celeris Therapeutics (CelerixTx) (Group) |
Austria |
| Kroll, Ines (Berlin Capital Fund 200504 Senior Investment Manager) |
Investment Manager |
Triginta Capital (Group) |
Germany |
| Kromayer, Matthias (MIG Funds 201009) |
General Partner (venture partner) |
MIG Fonds (Group) |
Germany |
| Kronabel, Christoph (Heidelberg Innovation 200306 Managing Director) |
Managing Director |
Heidelberg Innovation (Group) |
Germany |
| Kronbach, Thomas (Tom) (Biocrea 201010– CEO before Elbion/Biotie (D) CSO) |
Chief Executive Officer (CEO) |
Biocrea GmbH |
Germany |
| Krone, Dorothee (Prolytic GmbH 202009 Managing Director + Founder) |
Managing Director |
Kymos (Group) |
Germany |
| Kronemeyer, Wolfgang (Qiagen GmbH 200803) |
n. a. |
Qiagen (Group) |
Germany |
| Krossing, Ingo (Univ Freiburg 201603 Professor) |
Professor |
University of Freiburg (Albert-Ludwigs-Universität Freiburg) |
Germany |
| Krotzky, Arno J. (BASF 201012 Managing Director of Metanomics Health GmbH) |
Managing Director |
Biocrates (Group) |
Germany |
| Krug, Andreas (Medical Park Hannover 201103 Managing Director) |
Managing Director |
Medical Park Hannover GmbH |
Germany |
| Krug, Daniel (Helmholtz 201905 Assisant Prof at HIPS) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Kruisbeek, Ada (DCPrime BV 201710 CEO + CSO + Founder) |
Chief Executive Officer (CEO) |
Mendus (Group) |
Netherlands |
| Kruize, Niels (LGC 201108 Sales Director LGC Genomics) |
Sales Manager / Marketing Manager |
LGC (Group) |
United Kingdom (GB) |
| Krul, Mark (Aglaia BioMedical Ventures 2003– Founder before NDDO Research Foundation) |
Investment Manager |
Aglaia (VC) (Group) |
Netherlands |
| Krupa, Jörn (Helmholtz 201502 Director Technology Transfer) |
IP Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Krupik, Ruben (Clal Biotechnology 200704 CEO) |
Chief Executive Officer (CEO) |
Clal Industries and Investments Ltd. (Group) |
Israel |
| Krupp, Guido (AmpTec 200810 Managing Director before artus) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Kruppa, Gary (Bruker Corp 201709 VP Omics Solutions before MRM Proteomics 201407– CEO + VP BusDev at Bruker Daltonics) |
Chief Executive Officer (CEO) |
MRM Proteomics Inc. |
Canada |
| Kruse, Charli (Fraunhofer 201109 Head of Fraunhofer EMB) |
President/Director/Head Business Group/Unit/Division |
Fraunhofer (Group) |
Germany |
| Kruse, Christina (Conpega 201102 Managing Director Conpega Hamburg) |
Managing Director |
Conpega (Group) |
Germany |
| Kruse, Lothar (Impetus GmbH 200902 Managing Director) |
Managing Director |
Impetus Bioscience (Group) |
Germany |
| Kruse, Stephan (Dräger 202104 Head of Business Unit Therapy) |
President/Director/Head Business Group/Unit/Division |
Dräger (Group) |
Germany |
| Kruse, Tobias (Trials24 201708– Managing Director + Founder) |
Managing Director |
Trials24 GmbH |
Germany |
| Krüger, Gerd (Bayer 202302 President Radiology) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Krüger, Lars (Gensoric GmbH 201101 Managing Director) |
Managing Director |
Gensoric GmbH |
Germany |
| Krüll, Christoph (Danaher 201107 Marketing Manager Europe Beckman Coulter GmbH) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Germany |
| Krzyzak, Lena (High-Tech Gründerfonds 201609) |
n. a. |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Krähenbühl, Oliver (InSphero 201510– CFO before HG Global + Canon + JobCloud) |
Chief Financial Officer (CFO) |
InSphero (Group) |
Switzerland |
| Krähmer, Ralf (Celares 202307 Managing Director + Co-Founder) |
Managing Director |
Biosynth (since 9/22) (Group) |
Germany |
| Krämer, Johannes (PHAST 201805 Manging Director + Owner + Founder) |
Managing Director |
Eurofins (Group) |
Germany |
| Krämer, Thomas (Univ Zürich 201504 Professor) |
Professor |
University of Zurich (UZH) |
Switzerland |
| Kröger, René M. (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Kröger-Lui, Niels Gerridt (IRM² Infrarot Mikroskopie und Messtechnik GmbH 201703–Managing Director) |
Managing Director |
Bruker (Group) |
Germany |
| Kubacki, Ludwig (Evosciences 201707 European Sales Manager) |
Sales Manager / Marketing Manager |
Evosciences (Group) |
France |
| Kuballa, Jürgen (GALAB Laboratories GmbH 201203 Managing Director) |
Managing Director |
GALAB Technologies GmbH |
Germany |
| Kubias, Karel (i&i Biotech Fund 202202 Partner + former CEO of Czech subsidiary of Merck KGaA) |
Managing Director |
i&i (Group) |
Luxembourg |
| Kubin, Andreas (Inoxia Lifesciences GmbH 201212 Managing Director + Founder) |
Managing Director |
Inoxia Lifesciences GmbH |
Austria |
| Kubista, Mikael (TATAA Biocenter 201610 President) |
President/Director/Head Business Group/Unit/Division |
TATAA Biocenter AB |
Sweden |
| Kubota, Kiichi (PeptiDream 201504 CEO) |
Chief Executive Officer (CEO) |
PeptiDream Inc. (JP) |
Japan |
| Kucera, Tomas (Saphetor 201912 Head of Business Development) |
Business Development Manager / Strategy Manager |
Saphetor S.A. (VarSome) |
Switzerland |
| Kuchejda, Mathis (SPECTARIS 201605 Chairman) |
Board member |
SPECTARIS – Deutscher Industrieverband für optische, medizinische und mechatronische Technologien e. V. |
Germany |
| Kuck, Dietmar (Univ Bielefeld 201007 Professor for Organic Chemistry) |
Professor |
University of Bielefeld, Dept. of Chemistry |
Germany |
| Kuebelbeck, Armin (Silvacx 201802 Head of Project before Merck KGaA) |
President/Director/Head Business Group/Unit/Division |
Silvacx (project group at LSI) |
Germany |
| Kuepper, Jannis (Biosynth Carobsynth 202011 General Manager) |
General Manager (management) |
Biosynth (since 9/22) (Group) |
Switzerland |
| Kueppers, Evert (Pevion Biotech 201009– CEO before Pieris AG CEO before IDEA AG Head Business Development) |
Chief Executive Officer (CEO) |
Pevion Biotech AG |
Switzerland |
| Kuhlendahl, Susanne (Immundiagnostik AG 201210) |
n. a. |
Immundiagnostik (Group) |
Germany |
| Kuhlendahl, Sven (Progen Biotechnik GmbH 201706 General Manager) |
Managing Director |
R-Biopharm (Group) |
Germany |
| Kuhlmann-Lehmkuhle, Peter (Melchers 201011 Managing Director + Owner) |
Managing Director |
Melchers (Group) |
Germany |
| Kuhn, Hans (Altona Diagnostics 201203– before Norgenta) |
n. a. |
Altona Diagnostics (Group) |
Germany |
| Kuhn, Thomas (Poxel 200904– CEO) |
Chief Executive Officer (CEO) |
Poxel (Group) |
France |
| Kuhnert, Marcus (Merck (DE) 201408– CFO before CFO of Henkel Laundry + Home Care businss unit) |
Chief Financial Officer (CFO) |
Merck (DE) (Group) |
Germany |
| Kuhnert, Nikolai (Jacobs Univ 201003 Professor of Chemistry) |
Professor |
Schaffhausen Institute of Technology (SIT) |
Germany |
| Kuhrt, Michael (Biocom 201007 COO) |
Chief Operating Officer (COO) |
Biocom (Group) |
Germany |
| Kukatz, Ingo (vierviertel 201504 Managing Partner) |
Managing Director |
vierviertel – Agentur für Kommunikationsdesign GmbH |
Germany |
| Kukuk, Nicole (BIO Deutschland 201609) |
n. a. |
BIO Deutschland e. V. |
Germany |
| Kukutai, Arama (Finistere Ventures 201502 Partner + Co-founder) |
Venture Partner |
Finistere Partners LLC (Finistere Ventures) |
United States (USA) |
| Kulak, Nils A. (PreOmics GmbH 201601– Managing Director + Co-Founder) |
Managing Director |
Bruker (Group) |
Germany |
| Kulick, Stefan (KSK Diagnostics GmbH 201704 CEO + Co-Founder) |
Managing Director |
KSK Diagnostics GmbH |
Germany |
| Kulkarni, Abhijit (Abhi) (Cellino 202206– COO before Medtronic + Advanced Bionics + Bose Corp) |
Chief Operating Officer (COO) |
Cellino Biotech Inc. |
United States (USA) |
| Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO) |
Chief Executive Officer (CEO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Kull, Toomas (Cabinet Privé de Conseils 202009) |
Public Relations Manager / Investor Relations Manager |
Cabinet Privé de Conseils S.A. |
Switzerland |
| Kullmann, Christian (Evonik 202206 CEO) |
Chief Executive Officer (CEO) |
Evonik (Group) |
Germany |
| Kumar, Aman (Oaktree 202208 Co-Portolio Manager of Life Sciences Lending at Oaktree Capital Management) |
n. a. |
Oaktree Capital Management L.P. |
|
| Kumar, Hemant (Rentschler 201911– VP Process Sciences Rentschler Biopharma Inc before AnaptysBio + Merck) |
n. a. |
Rentschler (Group) |
United States (USA) |
| Kumar, Karthiga (Invasight 202206 CEO + CSO + Co-Founder) |
Chief Executive Officer (CEO) |
Invasight AG |
Switzerland |
| Kumar, Nilesh (Wellington Management 202111– Private Biotech Investor before Novo Ventures + Merk Serono Ventures) |
Investment Manager |
Wellington Management Company LLP |
United States (USA) |
| Kumar, Sumeet (Innatera Nanosystems 202011 CEO) |
Chief Executive Officer (CEO) |
Innatera Nanosystems B.V. |
Netherlands |
| Kumar, Yadhu (GATC Biotech 201611 Head of BioIT Development) |
n. a. |
Eurofins (Group) |
Germany |
| Kuner, Michael (Nycomed 200802– Executive VP) |
Legal Manager |
Takeda (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 40 41 42 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
